Evidence map›Paper›PMID 41754478›Full record

ArticlePathogens (Basel, Switzerland)2026

Combined Effects of Amikacin and Methylene Blue-Mediated Photodynamic Therapy on

Florencia Mariani, Celeste R Costilla, Oscar J Oppezzo, Estela M Galvan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Florencia MarianiLaboratorio de Patogénesis Bacteriana, Departamento de Investigaciones Bioquímicas y Farmacéuticas, Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y Diagnóstico (CEBBAD), Universidad Maimónides, Hidalgo 775, Buenos Aires C1405BCK, Argentina.
Celeste R CostillaLaboratorio de Patogénesis Bacteriana, Departamento de Investigaciones Bioquímicas y Farmacéuticas, Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y Diagnóstico (CEBBAD), Universidad Maimónides, Hidalgo 775, Buenos Aires C1405BCK, Argentina.
Oscar J OppezzoComisión Nacional de Energía Atómica, Buenos Aires C1429BNP, Argentina.ORCID 0000-0001-6525-793X
Estela M GalvanLaboratorio de Patogénesis Bacteriana, Departamento de Investigaciones Bioquímicas y Farmacéuticas, Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y Diagnóstico (CEBBAD), Universidad Maimónides, Hidalgo 775, Buenos Aires C1405BCK, Argentina.ORCID 0000-0002-8940-0873

Funding

Agencia Nacional de Promocion Cientifica y Tecnologica (ANCyPT), Argentina PICT2021-GRF-TII-00119Fundacion Cientifica Felipe Fiorellino, Universidad Maimonides, Argentina Intramural2025
6 · The paper itself

Abstract

Diabetic foot ulcer (DFU) infections frequently involve biofilm formation and exhibit limited responsiveness to conventional antibiotic therapy. In particular,

Indexed as

AmikacinAnti-Bacterial AgentsBiofilmsDiabetic FootMethylene BluePhotochemotherapyPseudomonas aeruginosaPseudomonas InfectionsEnterococcus faecalisHumansMicrobial ViabilityPhotosensitizing AgentsAmikacinAnti-Bacterial AgentsMethylene BluePhotosensitizing Agentsantibioticsbiofilmdiabetic foot ulcermethylene blue-mediated photodynamic therapyPseudomonas aeruginosasequential antibiofilm treatment

Identifiers

PMID41754478
PMCPMC12942855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.